Objective: To examine the relationship between the use of sedative and neur
omuscular blocking agents during a patient's intensive care unit (ICU) stay
and subsequent measures of health-related quality of life.
Design: Cross-sectional mail survey and retrospective medical record abstra
ction of a prospectively identified cohort of lung injury patients.
Setting: ICUs in three teaching hospitals in a major metropolitan area.
Patients: Patients with acute lung injury (n = 24).
Interventions: None-observational study.
Measurements and Main Results:Patients' charts were reviewed for those pati
ents returning postdischarge quality-of-life questionnaires. Duration, dail
y dose, and route of administration for sedatives and neuromuscular blockin
g agents were abstracted from ICU flow sheets. Relationships among ICU vari
ables (days of sedation, days of neuromuscular blockade, and severity of il
lness as measured by Acute Physiology and Chronic Health Evaluation III sco
re) and outcomes (symptoms of depression and symptoms of posttraumatic stre
ss disorder) were assessed. Depressive symptoms at follow-up were correlate
d with days of sedation (p = .007), but not with days of neuromuscular bloc
kade or initial severity of illness. The composite posttraumatic stress dis
order symptom impact score was correlated with days of sedation (p = .006)
and days of neuromuscular blockade (p = .035), but not with initial severit
y of illness. There were no significant differences between the frequency o
f patients reporting a specific posttraumatic stress disorder symptom in th
e high sedation group and the low sedation group, and there were no signifi
cant differences in specific posttraumatic stress disorder symptoms between
the group that had received neuromuscular blockade and those who had not.
Conclusions: The use of sedatives and neuromuscular blocking agents in the
ICU is positively associated with subsequent measures of depression and pos
ttraumatic stress disorder symptoms 6-41 months after ICU treatment for acu
te lung injury.